408 related articles for article (PubMed ID: 24782859)
1. Mouse models to study dengue virus immunology and pathogenesis.
Zellweger RM; Shresta S
Front Immunol; 2014; 5():151. PubMed ID: 24782859
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines.
Züst R; Toh YX; Valdés I; Cerny D; Heinrich J; Hermida L; Marcos E; Guillén G; Kalinke U; Shi PY; Fink K
J Virol; 2014 Jul; 88(13):7276-85. PubMed ID: 24741106
[TBL] [Abstract][Full Text] [Related]
3. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection.
Pinto AK; Brien JD; Lam CY; Johnson S; Chiang C; Hiscott J; Sarathy VV; Barrett AD; Shresta S; Diamond MS
mBio; 2015 Sep; 6(5):e01316-15. PubMed ID: 26374123
[TBL] [Abstract][Full Text] [Related]
4. A lethal murine infection model for dengue virus 3 in AG129 mice deficient in type I and II interferon receptors leads to systemic disease.
Sarathy VV; White M; Li L; Gorder SR; Pyles RB; Campbell GA; Milligan GN; Bourne N; Barrett AD
J Virol; 2015 Jan; 89(2):1254-66. PubMed ID: 25392217
[TBL] [Abstract][Full Text] [Related]
5. A mouse model for studying dengue virus pathogenesis and immune response.
Williams KL; Zompi S; Beatty PR; Harris E
Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E12-23. PubMed ID: 19751398
[TBL] [Abstract][Full Text] [Related]
6. Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing.
Frias-Staheli N; Dorner M; Marukian S; Billerbeck E; Labitt RN; Rice CM; Ploss A
J Virol; 2014 Feb; 88(4):2205-18. PubMed ID: 24335303
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of dengue virus infection and disease.
Yauch LE; Shresta S
Antiviral Res; 2008 Nov; 80(2):87-93. PubMed ID: 18619493
[TBL] [Abstract][Full Text] [Related]
8. Differential replicative ability of clinical dengue virus isolates in an immunocompetent C57BL/6 mouse model.
Barros VE; dos Santos-Junior NN; Amarilla AA; Soares AM; Lourencini R; Trabuco AC; Aquino VH
BMC Microbiol; 2015 Sep; 15():189. PubMed ID: 26415508
[TBL] [Abstract][Full Text] [Related]
9. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.
Galula JU; Shen WF; Chuang ST; Chang GJ; Chao DY
J Virol; 2014 Sep; 88(18):10813-30. PubMed ID: 25008922
[TBL] [Abstract][Full Text] [Related]
10. Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models.
Shukla R; Beesetti H; Brown JA; Ahuja R; Ramasamy V; Shanmugam RK; Poddar A; Batra G; Krammer F; Lim JK; Kale S; Lal AA; Swaminathan S; Khanna N
EBioMedicine; 2020 Oct; 60():102991. PubMed ID: 32949997
[TBL] [Abstract][Full Text] [Related]
11. Animal models of dengue virus infection.
Zompi S; Harris E
Viruses; 2012 Jan; 4(1):62-82. PubMed ID: 22355452
[TBL] [Abstract][Full Text] [Related]
12. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development.
Elong Ngono A; Shresta S
Front Immunol; 2019; 10():1316. PubMed ID: 31244855
[TBL] [Abstract][Full Text] [Related]
13. Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.
Uno N; Ross TM
J Virol; 2021 Jan; 95(4):. PubMed ID: 33208445
[TBL] [Abstract][Full Text] [Related]
14. Antibody Epitopes Identified in Critical Regions of Dengue Virus Nonstructural 1 Protein in Mouse Vaccination and Natural Human Infections.
Hertz T; Beatty PR; MacMillen Z; Killingbeck SS; Wang C; Harris E
J Immunol; 2017 May; 198(10):4025-4035. PubMed ID: 28381638
[TBL] [Abstract][Full Text] [Related]
15. A genetic and pathologic study of a DENV2 clinical isolate capable of inducing encephalitis and hematological disturbances in immunocompetent mice.
Amorim JH; Pereira Bizerra RS; dos Santos Alves RP; Sbrogio-Almeida ME; Levi JE; Capurro ML; de Souza Ferreira LC
PLoS One; 2012; 7(9):e44984. PubMed ID: 23028722
[TBL] [Abstract][Full Text] [Related]
16. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.
de Alwis R; Williams KL; Schmid MA; Lai CY; Patel B; Smith SA; Crowe JE; Wang WK; Harris E; de Silva AM
PLoS Pathog; 2014 Oct; 10(10):e1004386. PubMed ID: 25275316
[TBL] [Abstract][Full Text] [Related]
17. The human antibody response to dengue virus infection.
Wahala WM; Silva AM
Viruses; 2011 Dec; 3(12):2374-95. PubMed ID: 22355444
[TBL] [Abstract][Full Text] [Related]
18. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
[TBL] [Abstract][Full Text] [Related]
19. Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice.
Watanabe S; Tan NWW; Chan KWK; Vasudevan SG
J Infect Dis; 2019 Jan; 219(2):223-233. PubMed ID: 30085051
[TBL] [Abstract][Full Text] [Related]
20. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]